Emergent Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Emergent Biosolutions
EBS Stock  USD 11.91  0.04  0.33%   
Emergent Biosolutions' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Emergent Biosolutions' valuation are provided below:
Gross Profit
384.3 M
Profit Margin
0.0962
Market Capitalization
637.5 M
Enterprise Value Revenue
1.3923
Revenue
788.9 M
There are over one hundred nineteen available fundamental signals for Emergent Biosolutions, which can be analyzed over time and compared to other ratios. All traders should verify Emergent Biosolutions' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.8 B in 2026. Enterprise Value is likely to gain to about 1.7 B in 2026

Emergent Biosolutions Total Revenue

1.26 Billion

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 127.5 M, Interest Expense of 85.7 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.53, Dividend Yield of 0.018 or PTB Ratio of 1.15. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
  
Build AI portfolio with Emergent Stock
Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Emergent Biosolutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.6 B1.5 B
Slightly volatile
Short and Long Term Debt Total388.9 M777.5 M508.8 M
Slightly volatile
Other Current Liabilities72.6 M113.6 M90.5 M
Slightly volatile
Total Current Liabilities228 M186.8 M270.9 M
Slightly volatile
Property Plant And Equipment Net375.6 M311.2 M443.7 M
Pretty Stable
Accounts Payable61.9 M70 M73.4 M
Slightly volatile
Cash212.3 M114.4 M245.4 M
Pretty Stable
Non Current Assets Total802.3 M909.6 M995.5 M
Slightly volatile
Non Currrent Assets Other38 M21.7 M45.9 M
Slightly volatile
Cash And Short Term Investments212.5 M114.4 M245.5 M
Pretty Stable
Net Receivables136.8 M177.7 M166.2 M
Slightly volatile
Good Will142.1 M250.9 M149.7 M
Slightly volatile
Common Stock Shares Outstanding42.1 M61 M46.5 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.6 B1.5 B
Slightly volatile
Non Current Liabilities Total899 M856.2 M576.5 M
Slightly volatile
Inventory376.4 M358.5 M206.9 M
Slightly volatile
Other Current Assets24.5 M38 M30.1 M
Slightly volatile
Total Liabilities549.3 M1 B732.4 M
Slightly volatile
Total Current Assets535.8 M688.5 M672.9 M
Slightly volatile
Short Term Debt2.9 M3.1 M100.2 M
Slightly volatile
Intangible Assets404.7 M576.7 M401 M
Slightly volatile
Common Stock63.6 K115 K73.9 K
Slightly volatile
Other Liabilities66.7 M104 M83 M
Slightly volatile
Current Deferred Revenue20.7 M30.4 M26 M
Slightly volatile
Long Term Debt801.4 M763.3 M429.9 M
Slightly volatile
Common Stock Total Equity120.8 K115 K72.5 K
Slightly volatile
Property Plant And Equipment Gross396.8 M767.9 M477.2 M
Slightly volatile
Property Plant Equipment356 M324.6 M402.8 M
Slightly volatile
Net Tangible Assets1 B1.6 B954.7 M
Slightly volatile
Long Term Debt Total536.9 M763.3 M418.1 M
Slightly volatile
Capital Surpluse726.1 M1.1 B595 M
Slightly volatile
Non Current Liabilities Other72.7 M45 M54.2 M
Slightly volatile
Short and Long Term Debt499.5 M475.8 M257.9 M
Slightly volatile
Deferred Long Term Asset Charges9 M10.2 M11.1 M
Slightly volatile
Cash And Equivalents108.7 M114.4 M272.5 M
Very volatile
Net Invested Capital2 B1.3 B1.5 B
Slightly volatile
Capital Stock80 K90 K98.2 K
Slightly volatile

Emergent Biosolutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization127.5 M121.4 M72.9 M
Slightly volatile
Total Revenue1.3 B1.2 B810 M
Slightly volatile
Other Operating Expenses1.4 B1.3 B866.2 M
Slightly volatile
Research Development122.8 M81.3 M142.2 M
Very volatile
Cost Of Revenue806.9 M768.4 M480.5 M
Slightly volatile
Total Operating Expenses294.2 M556.7 M368.6 M
Slightly volatile
Income Tax Expense57.6 M54.9 M36.2 M
Slightly volatile
Selling General Administrative177.9 M354.2 M206.9 M
Slightly volatile
Tax Provision48.8 M54.9 M45.2 M
Pretty Stable
Interest Income85.7 M81.7 M30.4 M
Slightly volatile
Reconciled Depreciation115.1 M125.1 M80.9 M
Slightly volatile

Emergent Biosolutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation19.3 M20.7 M21.5 M
Slightly volatile
Begin Period Cash Flow227.2 M128.5 M251.4 M
Slightly volatile
Depreciation131.4 M125.1 M72.6 M
Slightly volatile
Capital Expenditures25 M26.3 M67.1 M
Pretty Stable
End Period Cash Flow232.3 M121.4 M247.5 M
Pretty Stable
Change To Netincome44.4 M48.1 M38.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.530.562.1382
Slightly volatile
Dividend Yield0.0180.02020.0221
Slightly volatile
Days Sales Outstanding59.0362.14185
Slightly volatile
Stock Based Compensation To Revenue0.01880.01980.0828
Slightly volatile
Capex To Depreciation0.230.241.5892
Slightly volatile
EV To Sales1.131.192.3845
Slightly volatile
Inventory Turnover3.592.473.6128
Slightly volatile
Days Of Inventory On Hand171196146
Slightly volatile
Payables Turnover10.379.876.5698
Slightly volatile
Sales General And Administrative To Revenue0.320.30.2772
Pretty Stable
Research And Ddevelopement To Revenue0.0740.07790.4482
Slightly volatile
Capex To Revenue0.0240.02520.3836
Slightly volatile
Cash Per Share1.611.695.1866
Very volatile
Payout Ratio0.270.310.336
Slightly volatile
Days Payables Outstanding36.3438.2673.3038
Slightly volatile
Intangibles To Total Assets0.390.412.3975
Slightly volatile
Current Ratio2.613.323.5244
Slightly volatile
Receivables Turnover7.137.774.9053
Slightly volatile
Capex Per Share0.470.52.1347
Slightly volatile
Revenue Per Share9.7317.7215.6337
Slightly volatile
Interest Debt Per Share13.3212.6910.8167
Slightly volatile
Debt To Assets0.230.440.3444
Very volatile
Graham Number49.8347.4632.6534
Slightly volatile
Operating Cycle344258338
Slightly volatile
Days Of Payables Outstanding36.3438.2673.3038
Slightly volatile
Dividend Payout Ratio0.270.310.336
Slightly volatile
Ebt Per Ebit1.121.511.0504
Pretty Stable
Long Term Debt To Capitalization0.550.520.3201
Slightly volatile
Total Debt To Capitalization0.640.671.6659
Slightly volatile
Quick Ratio2.882.032.7821
Slightly volatile
Net Income Per E B T1.261.20.8242
Slightly volatile
Cash Ratio0.670.71.4806
Slightly volatile
Days Of Inventory Outstanding171196146
Slightly volatile
Days Of Sales Outstanding59.0362.14185
Slightly volatile
Fixed Asset Turnover3.643.471.8859
Slightly volatile
Debt Ratio0.230.440.3444
Very volatile
Price Sales Ratio0.530.562.1382
Slightly volatile
Asset Turnover0.860.7510.6222
Pretty Stable

Emergent Biosolutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.7 B1.5 B
Slightly volatile
Enterprise Value1.7 B1.6 B1.4 B
Slightly volatile

Emergent Fundamental Market Drivers

Forward Price Earnings2.9727
Cash And Short Term Investments99.5 M

Emergent Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue30.4 M20.7 M
Total Revenue1.2 B1.3 B
Cost Of Revenue768.4 M806.9 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.32 
Research And Ddevelopement To Revenue 0.08  0.07 
Capex To Revenue 0.03  0.02 
Revenue Per Share 17.72  9.73 
Ebit Per Revenue(0.12)(0.11)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY